Showing results (231-240 of 537) with videos related to

Sort By:
Pageof 54
Headache|February 6, 2004
Efficacy and tolerability of oral zolmitriptan in menstrually associated migraine: a randomized, prospective, parallel-group, double-blind, placebo-controlled studyElizabeth Loder, Stephen D Silberstein, Susan Abu-Shakra, et al.
Headache|September 16, 2009
Scheduled short-term prevention with frovatriptan for migraine occurring exclusively in association with menstruationStephen D Silberstein, Todd Berner, John Tobin, et al.
Cephalalgia : an International Journal of Headache|July 25, 2020
The migraine landscape on YouTube: A review of YouTube as a source of information on migraineHillah Saffi, Thien Phu Do, Jakob Møller Hansen, et al.
Headache|November 9, 2020
Eptinezumab Demonstrated Efficacy in Sustained Prevention of Episodic and Chronic Migraine Beginning on Day 1 After DosingDavid W Dodick, Christopher Gottschalk, Roger Cady, et al.
Cephalalgia : an International Journal of Headache|July 4, 2020
Ubrogepant does not induce latent sensitization in a preclinical model of medication overuse headacheEdita Navratilova, Sasan Behravesh, Janice Oyarzo, et al.
Headache|March 29, 2021
Impact of abuse on migraine-related sensory hypersensitivity symptoms: Results from the American Registry for Migraine ResearchMeesha Trivedi, Gina Dumkrieger, Catherine D Chong, et al.
Cephalalgia : an International Journal of Headache|July 25, 2020
Googling migraine: A study of Google as an information resource of migraine managementRachid Bojazar, Thien Phu Do, Jakob Møller Hansen, et al.
Headache|April 20, 2005
Duration of migraine is a predictor for response to botulinum toxin type AEric J Eross, Jonathan P Gladstone, Susan Lewis, et al.
Cephalalgia : an International Journal of Headache|October 5, 2012
Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: results from a randomized, multicenter, double-blinded, controlled studyStephen D Silberstein, David W Dodick, Joel Saper, et al.
Current Medical Research and Opinion|July 19, 2006
The impact of migraine on daily activities: effect of topiramate compared with placeboStephen D Silberstein, Elizabeth Loder, Grace Forde, et al.
Pageof 54